Yellowstone Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-1,068
Closed -$203K 190
2017
Q3
$203K Buy
+1,068
New +$203K 0.11% 174
2016
Q3
$221K Buy
+1,761
New +$227K 0.08% 203

Other funds holding ELV

Yellowstone Partners's ELV Position: Q4 2017 in Review

Yellowstone Partners sold out of Elevance Health (ELV) in Q4 2017, closing a stake of 1,068 shares — an estimated $203K sold.

Yellowstone Partners first reported a position in ELV in Q3 2016 and held it in 2 quarters. The position peaked at $221K in Q3 2016. 909 funds tracked by Wall St. Rank hold ELV as of Q4 2017.

  • Yellowstone Partners reported no remaining Elevance Health position as of Q4 2017 after selling out during the quarter.
  • Yellowstone Partners sold 1,068 Elevance Health shares in Q4 2017, an estimated $203K.
  • Yellowstone Partners first reported a position in Elevance Health in Q3 2016 and held it in 2 quarters.
  • Yellowstone Partners's Elevance Health position peaked at $221K in Q3 2016.
  • 909 funds tracked by Wall St. Rank held Elevance Health as of Q4 2017.

Based on Yellowstone Partners's 13F filing for Q4 2017, filed 24 Jan 2018.